News
ASCO honors Hagop Kantarjian, MD, for leukemia research
Noted Lebanese-American oncologist who leads the leukemia department at MD Anderson Cancer Center is to receive a top award at ASCO 2023.
News
Deep sleep may mitigate the impact of Alzheimer’s pathology
“Think of deep sleep almost like a life raft that keeps memory afloat, rather than memory getting dragged down by the weight of Alzheimer’s...
News
Parkinson’s in Marines linked to toxic drinking water at Camp Lejeune
“This is by far the largest study to look at the association of TCE and PD and the evidence is pretty strong.”
News
Common gut bacteria linked to Parkinson’s disease
The findings highlight the potential for screening and targeted removal of harmful Desulfovibrio bacteria.
News
FDA moves to curb misuse of ADHD meds
The boxed warning will also advise heath care professionals to monitor patients closely for signs and symptoms of misuse, abuse, and addiction.
News
Statins appear to guard against liver disease progression
This study “continues the theme that cholesterol-lowering statins are good for a lot more things than just lowering cholesterol.”
News
Key red flags for early-onset colorectal cancer
Two symptoms in particular – rectal bleeding and iron-deficiency anemia – point to the need for timely endoscopy and follow-up.
News
ChatGPT delivers credible answers to colonoscopy queries
"This study shows that a conversational AI program can generate credible medical information in response to common patient questions."
News
Anxiety high among Americans, national poll shows
“There is a lot of worry in the world right now about economic uncertainty, about violence, about how we’re going to come out of this period of...
News
FDA OKs new drug for Fabry disease
“The totality of clinical data suggests that Elfabrio has the potential to be a long-lasting therapy.”
News
FDA approves first drug to treat Alzheimer’s agitation
“Agitation is one of the most common and challenging aspects of care among patients with dementia due to Alzheimer’s disease.”
News
FDA expands use of dapagliflozin to broader range of HF
The sodium-glucose cotransporter 2 inhibitor was previously approved in the United States for adults with heart failure with reduced ejection...
News
AHA flags differing CVD risk in Asian American subgroups
Together, T2D and ASCVD are the leading causes of illness and death among Asian American adults, but there is significant variability in...
News
Young men at highest schizophrenia risk from cannabis abuse
For young men aged 21-30, the proportion of preventable schizophrenia cases related to cannabis abuse disorder may be as high as 30%.
News
Asthma tied to increased risk for multiple cancers
Treatment with an inhaled steroid may lower that risk, perhaps by keeping inflammation in check.